Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Evolutionary dynamics of the cryptocurrency market.

Royal Society open science

ElBahrawy A, Alessandretti L, Kandler A, Pastor-Satorras R, Baronchelli A.
PMID: 29291057
R Soc Open Sci. 2017 Nov 15;4(11):170623. doi: 10.1098/rsos.170623. eCollection 2017 Nov.

The cryptocurrency market surpassed the barrier of $100 billion market capitalization in June 2017, after months of steady growth. Despite its increasing relevance in the financial world, a comprehensive analysis of the whole system is still lacking, as most...

Cite
ElBahrawy A, Alessandretti L, Kandler A, et al. Evolutionary dynamics of the cryptocurrency market. R Soc Open Sci. 2017;4(11):170623doi: 10.1098/rsos.170623.
ElBahrawy, A., Alessandretti, L., Kandler, A., Pastor-Satorras, R., & Baronchelli, A. (2017). Evolutionary dynamics of the cryptocurrency market. Royal Society open science, 4(11), 170623. https://doi.org/10.1098/rsos.170623
ElBahrawy, Abeer, et al. "Evolutionary dynamics of the cryptocurrency market." Royal Society open science vol. 4,11 (2017): 170623. doi: https://doi.org/10.1098/rsos.170623
ElBahrawy A, Alessandretti L, Kandler A, Pastor-Satorras R, Baronchelli A. Evolutionary dynamics of the cryptocurrency market. R Soc Open Sci. 2017 Nov 15;4(11):170623. doi: 10.1098/rsos.170623. eCollection 2017 Nov. PMID: 29291057; PMCID: PMC5717631.
Copy Download .nbib Format: NLM
Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases.

Cancer biology & medicine

Lin CC, Wu CH, Chen LY, Tsai MC, Elsarawy AM, Huang KT.
PMID: 30197794
Cancer Biol Med. 2018 Aug;15(3):275-281. doi: 10.20892/j.issn.2095-3941.2017.0144.

OBJECTIVE: : Coagulation factor VII (FVII) triggers the extrinsic pathway of blood coagulation. In our previous study, we showed that FVII plays an important role in tumorigenesis of hepatocellular carcinoma (HCC). However, the role of FVII polymorphism in HCC...

Cite
Lin CC, Wu CH, Chen LY, et al. Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases. Cancer Biol Med. 2018;15(3):275-281doi: 10.20892/j.issn.2095-3941.2017.0144.
Lin, C. C., Wu, C. H., Chen, L. Y., Tsai, M. C., Elsarawy, A. M., & Huang, K. T. (2018). Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases. Cancer biology & medicine, 15(3), 275-281. https://doi.org/10.20892/j.issn.2095-3941.2017.0144
Lin, Chih-Che, et al. "Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases." Cancer biology & medicine vol. 15,3 (2018): 275-281. doi: https://doi.org/10.20892/j.issn.2095-3941.2017.0144
Lin CC, Wu CH, Chen LY, Tsai MC, Elsarawy AM, Huang KT. Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases. Cancer Biol Med. 2018 Aug;15(3):275-281. doi: 10.20892/j.issn.2095-3941.2017.0144. PMID: 30197794; PMCID: PMC6121054.
Copy Download .nbib Format: NLM
Resuscitative endovascular balloon occlusion of the aorta (REBOA): indications: advantages and challenges of implementation in traumatic non-compressible torso hemorrhage.

Trauma surgery & acute care open

Bekdache O, Paradis T, Shen YBH, Elbahrawy A, Grushka J, Deckelbaum D, Khwaja K, Fata P, Razek T, Beckett A.
PMID: 31245615
Trauma Surg Acute Care Open. 2019 Apr 15;4(1):e000262. doi: 10.1136/tsaco-2018-000262. eCollection 2019.

BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is regaining popularity in the treatment of traumatic non-compressible torso bleeding. Advances in invasive radiology coupled with new damage control measures assisted in the refinement of the technique with promising...

Cite
Bekdache O, Paradis T, Shen YBH, et al. Resuscitative endovascular balloon occlusion of the aorta (REBOA): indications: advantages and challenges of implementation in traumatic non-compressible torso hemorrhage. Trauma Surg Acute Care Open. 2019;4(1):e000262doi: 10.1136/tsaco-2018-000262.
Bekdache, O., Paradis, T., Shen, Y. B. H., Elbahrawy, A., Grushka, J., Deckelbaum, D., Khwaja, K., Fata, P., Razek, T., & Beckett, A. (2019). Resuscitative endovascular balloon occlusion of the aorta (REBOA): indications: advantages and challenges of implementation in traumatic non-compressible torso hemorrhage. Trauma surgery & acute care open, 4(1), e000262. https://doi.org/10.1136/tsaco-2018-000262
Bekdache, Omar, et al. "Resuscitative endovascular balloon occlusion of the aorta (REBOA): indications: advantages and challenges of implementation in traumatic non-compressible torso hemorrhage." Trauma surgery & acute care open vol. 4,1 (2019): e000262. doi: https://doi.org/10.1136/tsaco-2018-000262
Bekdache O, Paradis T, Shen YBH, Elbahrawy A, Grushka J, Deckelbaum D, Khwaja K, Fata P, Razek T, Beckett A. Resuscitative endovascular balloon occlusion of the aorta (REBOA): indications: advantages and challenges of implementation in traumatic non-compressible torso hemorrhage. Trauma Surg Acute Care Open. 2019 Apr 15;4(1):e000262. doi: 10.1136/tsaco-2018-000262. eCollection 2019. PMID: 31245615; PMCID: PMC6560484.
Copy Download .nbib Format: NLM
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities.

International archives of otorhinolaryngology

Khater A, El-Anwar MW, Nofal AA, Elbahrawy AT.
PMID: 29983762
Int Arch Otorhinolaryngol. 2018 Jul;22(3):245-249. doi: 10.1055/s-0037-1605376. Epub 2017 Sep 12.

No abstract available.

Cite
Khater A, El-Anwar MW, Nofal AA, et al. Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities. Int Arch Otorhinolaryngol. 2017;22(3):245-249doi: 10.1055/s-0037-1605376.
Khater, A., El-Anwar, M. W., Nofal, A. A., & Elbahrawy, A. T. (2018). Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities. International archives of otorhinolaryngology, 22(3), 245-249. https://doi.org/10.1055/s-0037-1605376
Khater, Ahmed, et al. "Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities." International archives of otorhinolaryngology vol. 22,3 (2018): 245-249. doi: https://doi.org/10.1055/s-0037-1605376
Khater A, El-Anwar MW, Nofal AA, Elbahrawy AT. Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities. Int Arch Otorhinolaryngol. 2018 Jul;22(3):245-249. doi: 10.1055/s-0037-1605376. Epub 2017 Sep 12. PMID: 29983762; PMCID: PMC6033594.
Copy Download .nbib Format: NLM
Changing Patterns of Hepatocellular Carcinoma after Treatment with Direct Antiviral Agents.

Gastrointestinal tumors

El Fayoumie M, Abdelhady M, Gawish A, Hantour U, Abdelkhaleek I, Abdelraheem M, Alsawak A, Alwassief A, Elbahrawy A.
PMID: 32399465
Gastrointest Tumors. 2020 Apr;7(1):50-60. doi: 10.1159/000505326. Epub 2020 Jan 17.

INTRODUCTION: The impact of direct antiviral agents (DAAs) on the development of hepatocellular carcinoma (HCC) is controversial. One important aspect of this controversy is the changing pattern of HCC.OBJECTIVE: In this study, we attempted to assess the changes in...

Cite
El Fayoumie M, Abdelhady M, Gawish A, et al. Changing Patterns of Hepatocellular Carcinoma after Treatment with Direct Antiviral Agents. Gastrointest Tumors. 2020;7(1):50-60doi: 10.1159/000505326.
El Fayoumie, M., Abdelhady, M., Gawish, A., Hantour, U., Abdelkhaleek, I., Abdelraheem, M., Alsawak, A., Alwassief, A., & Elbahrawy, A. (2020). Changing Patterns of Hepatocellular Carcinoma after Treatment with Direct Antiviral Agents. Gastrointestinal tumors, 7(1), 50-60. https://doi.org/10.1159/000505326
El Fayoumie, Mohammed, et al. "Changing Patterns of Hepatocellular Carcinoma after Treatment with Direct Antiviral Agents." Gastrointestinal tumors vol. 7,1 (2020): 50-60. doi: https://doi.org/10.1159/000505326
El Fayoumie M, Abdelhady M, Gawish A, Hantour U, Abdelkhaleek I, Abdelraheem M, Alsawak A, Alwassief A, Elbahrawy A. Changing Patterns of Hepatocellular Carcinoma after Treatment with Direct Antiviral Agents. Gastrointest Tumors. 2020 Apr;7(1):50-60. doi: 10.1159/000505326. Epub 2020 Jan 17. PMID: 32399465; PMCID: PMC7206583.
Copy Download .nbib Format: NLM
Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease.

Clinical ophthalmology (Auckland, N.Z.)

Quah Qin Xian N, Alnahrawy A, Akshikar R, Lee V.
PMID: 34007144
Clin Ophthalmol. 2021 May 10;15:1921-1932. doi: 10.2147/OPTH.S305717. eCollection 2021.

PURPOSE: There is no universal consensus on second-line agents for the treatment of moderate/severe to sight-threatening thyroid eye disease (TED) to maintain remission after first-line intravenous methylprednisolone (IVMP). This study investigates the efficacy and safety of mycophenolate mofetil (MMF)...

Cite
Quah Qin Xian N, Alnahrawy A, Akshikar R, et al. Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease. Clin Ophthalmol. 2021;15:1921-1932doi: 10.2147/OPTH.S305717.
Quah Qin Xian, N., Alnahrawy, A., Akshikar, R., & Lee, V. (2021). Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease. Clinical ophthalmology (Auckland, N.Z.), 151921-1932. https://doi.org/10.2147/OPTH.S305717
Quah Qin Xian, Nicole, et al. "Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease." Clinical ophthalmology (Auckland, N.Z.) vol. 15 (2021): 1921-1932. doi: https://doi.org/10.2147/OPTH.S305717
Quah Qin Xian N, Alnahrawy A, Akshikar R, Lee V. Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease. Clin Ophthalmol. 2021 May 10;15:1921-1932. doi: 10.2147/OPTH.S305717. eCollection 2021. PMID: 34007144; PMCID: PMC8121682.
Copy Download .nbib Format: NLM
Regular arrangement of collecting venules: Does patient age affect its accuracy?.

World journal of gastrointestinal endoscopy

Alaboudy A, Elbahrawy A, Matsumoto S, Galal GM, Chiba T.
PMID: 21860679
World J Gastrointest Endosc. 2011 Jun 16;3(6):118-23. doi: 10.4253/wjge.v3.i6.118.

AIM: To address the diagnostic value of the regular arrangement of collecting venules (RAC) among old age patients.METHODS: A total of 390 consecutive patients whose Helicobacter pylori (H. pylori) status was known and who received upper gastrointestinal endoscopy, were...

Cite
Alaboudy A, Elbahrawy A, Matsumoto S, et al. Regular arrangement of collecting venules: Does patient age affect its accuracy?. World J Gastrointest Endosc. 2011;3(6):118-23doi: 10.4253/wjge.v3.i6.118.
Alaboudy, A., Elbahrawy, A., Matsumoto, S., Galal, G. M., & Chiba, T. (2011). Regular arrangement of collecting venules: Does patient age affect its accuracy?. World journal of gastrointestinal endoscopy, 3(6), 118-23. https://doi.org/10.4253/wjge.v3.i6.118
Alaboudy, Alshimaa, et al. "Regular arrangement of collecting venules: Does patient age affect its accuracy?." World journal of gastrointestinal endoscopy vol. 3,6 (2011): 118-23. doi: https://doi.org/10.4253/wjge.v3.i6.118
Alaboudy A, Elbahrawy A, Matsumoto S, Galal GM, Chiba T. Regular arrangement of collecting venules: Does patient age affect its accuracy?. World J Gastrointest Endosc. 2011 Jun 16;3(6):118-23. doi: 10.4253/wjge.v3.i6.118. PMID: 21860679; PMCID: PMC3158903.
Copy Download .nbib Format: NLM
Diabetic Ketoacidosis Following Bariatric Surgery in Patients With Type 2 Diabetes.

Diabetes care

Andalib A, Elbahrawy A, Alshlwi S, Alkhamis A, Hu W, Demyttenaere S, Aggarwal R, Court O.
PMID: 27208337
Diabetes Care. 2016 Aug;39(8):e121-2. doi: 10.2337/dc16-0280. Epub 2016 May 10.

No abstract available.

Cite
Andalib A, Elbahrawy A, Alshlwi S, et al. Diabetic Ketoacidosis Following Bariatric Surgery in Patients With Type 2 Diabetes. Diabetes Care. 2016;39(8):e121-2doi: 10.2337/dc16-0280.
Andalib, A., Elbahrawy, A., Alshlwi, S., Alkhamis, A., Hu, W., Demyttenaere, S., Aggarwal, R., & Court, O. (2016). Diabetic Ketoacidosis Following Bariatric Surgery in Patients With Type 2 Diabetes. Diabetes care, 39(8), e121-2. https://doi.org/10.2337/dc16-0280
Andalib, Amin, et al. "Diabetic Ketoacidosis Following Bariatric Surgery in Patients With Type 2 Diabetes." Diabetes care vol. 39,8 (2016): e121-2. doi: https://doi.org/10.2337/dc16-0280
Andalib A, Elbahrawy A, Alshlwi S, Alkhamis A, Hu W, Demyttenaere S, Aggarwal R, Court O. Diabetic Ketoacidosis Following Bariatric Surgery in Patients With Type 2 Diabetes. Diabetes Care. 2016 Aug;39(8):e121-2. doi: 10.2337/dc16-0280. Epub 2016 May 10. PMID: 27208337.
Copy Download .nbib Format: NLM
Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease.

The Journal of invasive cardiology

El Amrawy AM, Loutfi MI, El Tahan SM, Ayad SW.
PMID: 34817397
J Invasive Cardiol. 2021 Dec;33(12):E960-E967. Epub 2021 Nov 24.

BACKGROUND: Long coronary lesions represent a formidable challenge during percutaneous coronary intervention (PCI). Implantation of multiple contiguous stents may result in sections of overlapping stents or gaps of unstented segments and is an independent predictor of restenosis and major...

Cite
El Amrawy AM, Loutfi MI, El Tahan SM, et al. Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease. J Invasive Cardiol. 2021;33(12):E960-E967
El Amrawy, A. M., Loutfi, M. I., El Tahan, S. M., & Ayad, S. W. (2021). Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease. The Journal of invasive cardiology, 33(12), E960-E967.
El Amrawy, Ahmed Mahmoud, et al. "Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease." The Journal of invasive cardiology vol. 33,12 (2021): E960-E967.
El Amrawy AM, Loutfi MI, El Tahan SM, Ayad SW. Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease. J Invasive Cardiol. 2021 Dec;33(12):E960-E967. Epub 2021 Nov 24. PMID: 34817397.
Copy Download .nbib Format: NLM
Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology

Ayad SW, El Zawawy TH, Lotfy MI, Naguib AM, El Amrawy AM.
PMID: 33826020
Egypt Heart J. 2021 Apr 07;73(1):36. doi: 10.1186/s43044-021-00160-x.

BACKGROUND: Significance of totally occluded culprit coronary artery in patients presenting with non-ST segment elevation myocardial infarction (NSTEMI) is underestimated. The aim of the study was to evaluate the incidence and impact of totally occluded culprit artery on in-hospital...

Cite
Ayad SW, El Zawawy TH, Lotfy MI, et al. Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome. Egypt Heart J. 2021;73(1):36doi: 10.1186/s43044-021-00160-x.
Ayad, S. W., El Zawawy, T. H., Lotfy, M. I., Naguib, A. M., & El Amrawy, A. M. (2021). Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome. The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology, 73(1), 36. https://doi.org/10.1186/s43044-021-00160-x
Ayad, Sherif W, et al. "Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome." The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology vol. 73,1 (2021): 36. doi: https://doi.org/10.1186/s43044-021-00160-x
Ayad SW, El Zawawy TH, Lotfy MI, Naguib AM, El Amrawy AM. Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome. Egypt Heart J. 2021 Apr 07;73(1):36. doi: 10.1186/s43044-021-00160-x. PMID: 33826020; PMCID: PMC8026781.
Copy Download .nbib Format: NLM
Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease.

The Journal of invasive cardiology

El Amrawy AM, Loutfi MI, El Tahan SM, Ayad SW.
PMID: 34817397
J Invasive Cardiol. 2021 Dec;33(12):E960-E967. Epub 2021 Nov 24.

BACKGROUND: Long coronary lesions represent a formidable challenge during percutaneous coronary intervention (PCI). Implantation of multiple contiguous stents may result in sections of overlapping stents or gaps of unstented segments and is an independent predictor of restenosis and major...

Cite
El Amrawy AM, Loutfi MI, El Tahan SM, et al. Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease. J Invasive Cardiol. 2021;33(12):E960-E967
El Amrawy, A. M., Loutfi, M. I., El Tahan, S. M., & Ayad, S. W. (2021). Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease. The Journal of invasive cardiology, 33(12), E960-E967.
El Amrawy, Ahmed Mahmoud, et al. "Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease." The Journal of invasive cardiology vol. 33,12 (2021): E960-E967.
El Amrawy AM, Loutfi MI, El Tahan SM, Ayad SW. Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease. J Invasive Cardiol. 2021 Dec;33(12):E960-E967. Epub 2021 Nov 24. PMID: 34817397.
Copy Download .nbib Format: NLM
Occult hepatitis B virus infection in Egypt.

World journal of hepatology

Elbahrawy A, Alaboudy A, El Moghazy W, Elwassief A, Alashker A, Abdallah AM.
PMID: 26140086
World J Hepatol. 2015 Jun 28;7(12):1671-8. doi: 10.4254/wjh.v7.i12.1671.

The emerging evidence of the potentially clinical importance of occult hepatitis B virus (HBV) infection (OBI) increases the interest in this topic. OBI may impact in several clinical contexts, which include the possible transmission of the infection, the contribution...

Cite
Elbahrawy A, Alaboudy A, El Moghazy W, et al. Occult hepatitis B virus infection in Egypt. World J Hepatol. 2015;7(12):1671-8doi: 10.4254/wjh.v7.i12.1671.
Elbahrawy, A., Alaboudy, A., El Moghazy, W., Elwassief, A., Alashker, A., & Abdallah, A. M. (2015). Occult hepatitis B virus infection in Egypt. World journal of hepatology, 7(12), 1671-8. https://doi.org/10.4254/wjh.v7.i12.1671
Elbahrawy, Ashraf, et al. "Occult hepatitis B virus infection in Egypt." World journal of hepatology vol. 7,12 (2015): 1671-8. doi: https://doi.org/10.4254/wjh.v7.i12.1671
Elbahrawy A, Alaboudy A, El Moghazy W, Elwassief A, Alashker A, Abdallah AM. Occult hepatitis B virus infection in Egypt. World J Hepatol. 2015 Jun 28;7(12):1671-8. doi: 10.4254/wjh.v7.i12.1671. PMID: 26140086; PMCID: PMC4483548.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries